Aptose Biosciences (TSE:APS)
TSX:APS
Holding TSE:APS?
Track your performance easily

Aptose Biosciences (APS) Stock Forecast & Price Target

130 Followers
See the Price Targets and Ratings of:

APS Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Aptose
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

APS Stock 12 Month Forecast

There Are No Analyst Ratings for TSE:APS In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

APS Financial Forecast

APS Earnings Forecast

The previous quarter’s earnings for APS were -C$0.51.
The previous quarter’s earnings for APS were -C$0.51.
No data currently available

APS Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
C$31.91C$9.71
Buy
1698.48%
Upside
Reiterated
06/14/24
Buy Rating on Aptose Biosciences Given Promising Tuspetinib Developments for AML Treatment
Canaccord Genuity
C$20.81C$8.32
Buy
1441.55%
Upside
Reiterated
05/15/24
Buy Rating for Aptose Biosciences on Tuspetinib's Promising AML Study and Synergistic Potential
Piper Sandler
C$6.94
Buy
1184.63%
Upside
Reiterated
04/03/24
Piper Sandler Keeps Their Buy Rating on Aptose Biosciences (APTO)
RBC Capital
C$31.91C$24.97
Buy
4524.65%
Upside
Reiterated
11/10/23
Aptose Biosciences price target lowered to $18 from $23 at RBC CapitalAptose Biosciences price target lowered to $18 from $23 at RBC Capital

Best Analysts Covering Aptose Biosciences

Which Analyst Should I Follow If I Want to Buy TSE:APS and Sell After:
1 Month
xxx
Success Rate
11/23 ratings generated profit
48%
Average Return
+0.17%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.83% of your transactions generating a profit, with an average return of +0.17% per trade.
3 Months
xxx
Success Rate
6/23 ratings generated profit
26%
Average Return
-14.64%
reiterated a xxx
rating a year ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 26.09% of your transactions generating a profit, with an average return of -14.64% per trade.
1 Year
Gregory RenzaRBC Capital
Success Rate
2/23 ratings generated profit
9%
Average Return
-35.33%
reiterated a buy rating a year ago
Copying Gregory Renza's trades and holding each position for 1 Year would result in 8.70% of your transactions generating a profit, with an average return of -35.33% per trade.
2 Years
xxx
Success Rate
2/18 ratings generated profit
11%
Average Return
-71.63%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -71.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APS Analyst Recommendation Trends

Rating
Mar 24
Apr 24
May 24
Jun 24
Aug 24
Strong Buy
6
5
5
4
3
Buy
0
0
0
0
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
5
5
4
4
In the current month, APS has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. APS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

APS Stock Forecast FAQ

What is TSE:APS’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSE:APS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSE:APS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TSE:APS a Buy, Sell or Hold?
      Currently, no data Available
      What is Aptose Biosciences’s price target?
      Currently, no data Available
      What do analysts say about Aptose Biosciences?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of TSE:APS?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis